Publications by authors named "Martin J Slade"

Claim this Profile
M
Measurements of EGFR expression on circulating tumor cells are reproducible over time in metastatic breast cancer patients.
Rachel E Payne, Ernesto Yagüe, Martin J Slade, Christos Apostolopoulos, Long R Jiao

Pharmacogenomics· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical significance of disseminated tumor cells in breast cancer.
Martin J Slade, R Charles Coombes

Nat Clin Pract Oncol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel HSV-1 virus, JS1/34.5-/47-, purges contaminating breast cancer cells from bone marrow.
Jennifer C Hu, Matthew J Booth, Gopichand Tripuraneni, Derek Davies, Syed A A Zaidi, Martin J Slade

Clin Cancer Res· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The importance of careful blood processing in isolation of cell-free DNA.
Karen Page, Tom Powles, Martin J Slade, Manuela Tamburo DE Bella, Rosemary A Walker

Ann N Y Acad Sci· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of RPIP9 (Rap2 interacting protein 9) is activated in breast carcinoma and correlates with a poor prognosis.
Selina Raguz, Manuela Tamburo De Bella, Martin J Slade, Christopher F Higgins, R Charles Coombes

Int J Cancer· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Voltage-gated sodium channel expression and potentiation of human breast cancer metastasis.
Scott P Fraser, James K J Diss, Athina-Myrto Chioni, Maria E Mycielska, Huiyan Pan, Martin J Slade

Clin Cancer Res· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative gefitinib versus gefitinib and anastrozole in postmenopausal patients with oestrogen-receptor positive and epidermal-growth-factor-receptor-positive primary breast cancer: a double-blind placebo-controlled phase II randomised trial.
Andreas Polychronis, H Dudley Sinnett, Dimitri Hadjiminas, Hemant Singhal, Janine L Mansi, Martin J Slade

Lancet Oncol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: results at 4 years.
Martin J Slade, Anjana Singh, Brendan M Smith, Gopi Tripuraneni, Emma Hall

Int J Cancer· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of the MDR1 upstream promoter in breast carcinoma as a surrogate for metastatic invasion.
Selina Raguz, Manuela Tamburo De Bella, Gopichani Tripuraneni, Martin J Slade, Christopher F Higgins

Clin Cancer Res· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reporter gene assay demonstrates functional differences in estrogen receptor activity in purified breast cancer cells: a pilot study.
Anjana Singh, Simak Ali, Manish S Kothari, Manuela Tamburo De Bella, Clive Smith, Martin J Slade

Int J Cancer· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis